Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Chem Biol ; 19(8): 1022-1030, 2023 08.
Article in English | MEDLINE | ID: mdl-37202521

ABSTRACT

Mammalian cell surface and secreted glycoproteins exhibit remarkable glycan structural diversity that contributes to numerous physiological and pathogenic interactions. Terminal glycan structures include Lewis antigens synthesized by a collection of α1,3/4-fucosyltransferases (CAZy GT10 family). At present, the only available crystallographic structure of a GT10 member is that of the Helicobacter pylori α1,3-fucosyltransferase, but mammalian GT10 fucosyltransferases are distinct in sequence and substrate specificity compared with the bacterial enzyme. Here, we determined crystal structures of human FUT9, an α1,3-fucosyltransferase that generates Lewisx and Lewisy antigens, in complex with GDP, acceptor glycans, and as a FUT9-donor analog-acceptor Michaelis complex. The structures reveal substrate specificity determinants and allow prediction of a catalytic model supported by kinetic analyses of numerous active site mutants. Comparisons with other GT10 fucosyltransferases and GT-B fold glycosyltransferases provide evidence for modular evolution of donor- and acceptor-binding sites and specificity for Lewis antigen synthesis among mammalian GT10 fucosyltransferases.


Subject(s)
Fucosyltransferases , Glycosyltransferases , Animals , Humans , Fucosyltransferases/genetics , Fucosyltransferases/chemistry , Fucosyltransferases/metabolism , Lewis Blood Group Antigens , Polysaccharides/metabolism , Mammals
2.
Nat Chem ; 11(2): 161-169, 2019 02.
Article in English | MEDLINE | ID: mdl-30532014

ABSTRACT

Contemporary chemoenzymatic approaches can provide highly complex multi-antennary N-linked glycans. These procedures are, however, very demanding and typically involve as many as 100 chemical steps to prepare advanced intermediates that can be diversified by glycosyltransferases in a branch-selective manner to give asymmetrical structures commonly found in nature. Only highly specialized laboratories can perform such syntheses, which greatly hampers progress in glycoscience. Here we describe a biomimetic approach in which a readily available bi-antennary glycopeptide can be converted in ten or fewer chemical and enzymatic steps into multi-antennary N-glycans that at each arm can be uniquely extended by glycosyltransferases to give access to highly complex asymmetrically branched N-glycans. A key feature of our approach is the installation of additional branching points using recombinant MGAT4 and MGAT5 in combination with unnatural sugar donors. At an appropriate point in the enzymatic synthesis, the unnatural monosaccharides can be converted into their natural counterpart, allowing each arm to be elaborated into a unique appendage.


Subject(s)
Biomimetic Materials/metabolism , Polysaccharides/metabolism , Asparagine/metabolism , Carbohydrate Sequence , Escherichia coli/enzymology , Escherichia coli Proteins/metabolism , Galactosidases/metabolism , Glycopeptides/metabolism , Glycosylation , N-Acetylglucosaminyltransferases/metabolism , Polysaccharides/chemistry , Sialyltransferases/metabolism
3.
Carbohydr Res ; 452: 122-128, 2017 Nov 27.
Article in English | MEDLINE | ID: mdl-29096185

ABSTRACT

Sialylglycopeptide (SGP) is a complex bi-antennary N-glycan bearing a short peptide fragment that can be isolated from the yolk of hen eggs. This natural product has gained popularity as a starting material for the semi-synthesis of N-glycans. We have found that current isolation methods provide a glycopeptide contaminated with several related structures, one being a glycopeptide having a hexose directly attached to peptide backbone, most like through the hydroxyl containing side chain of the threonine moiety. Furthermore, current methods employ fresh egg yolks that need to be lyophilized and involve several tedious purification steps. Herein, we report a convenient method for the isolation of gram quantities of homogeneous SGP from commercially available egg yolk powder using solid/liquid extraction and HILIC-HPLC purification.


Subject(s)
Glycopeptides/chemistry , Polysaccharides/chemistry , Chromatography, High Pressure Liquid
4.
Anal Chem ; 89(22): 12342-12350, 2017 11 21.
Article in English | MEDLINE | ID: mdl-29058413

ABSTRACT

Knowledge of lectin and glycosidase specificities is fundamental to the study of glycobiology. The primary specificities of such molecules can be uncovered using well-established tools, but the complex details of their specificities are difficult to determine and describe. Here we present a language and algorithm for the analysis and description of glycan motifs with high complexity. The language uses human-readable notation and wildcards, modifiers, and logical operators to define motifs of nearly any complexity. By applying the syntax to the analysis of glycan-array data, we found that the lectin AAL had higher binding where fucose groups are displayed on separate branches. The lectin SNA showed gradations in binding based on the length of the extension displaying sialic acid and on characteristics of the opposing branches. A new algorithm to evaluate changes in lectin binding upon treatment with exoglycosidases identified the primary specificities and potential fine specificities of an α1-2-fucosidase and an α2-3,6,8-neuraminidase. The fucosidase had significantly lower action where sialic acid neighbors the fucose, and the neuraminidase showed statistically lower action where α1-2 fucose neighbors the sialic acid or is on the opposing branch. The complex features identified here would have been inaccessible to analysis using previous methods. The new language and algorithms promise to facilitate the precise determination and description of lectin and glycosidase specificities.


Subject(s)
Glycoside Hydrolases/metabolism , Lectins/analysis , Microarray Analysis , Polysaccharides/chemistry , Algorithms , Binding Sites , Fucose/chemistry , Glycoside Hydrolases/analysis , Humans , Milk, Human/chemistry , Polysaccharides/chemical synthesis , Substrate Specificity
5.
Proc Natl Acad Sci U S A ; 114(27): 6954-6959, 2017 07 03.
Article in English | MEDLINE | ID: mdl-28630345

ABSTRACT

Despite mammalian glycans typically having highly complex asymmetrical multiantennary architectures, chemical and chemoenzymatic synthesis has almost exclusively focused on the preparation of simpler symmetrical structures. This deficiency hampers investigations into the biology of glycan-binding proteins, which in turn complicates the biomedical use of this class of biomolecules. Herein, we describe an enzymatic strategy, using a limited number of human glycosyltransferases, to access a collection of 60 asymmetric, multiantennary human milk oligosaccharides (HMOs), which were used to develop a glycan microarray. Probing the array with several glycan-binding proteins uncovered that not only terminal glycoepitopes but also complex architectures of glycans can influence binding selectivity in unanticipated manners. N- and O-linked glycans express structural elements of HMOs, and thus, the reported synthetic principles will find broad applicability.


Subject(s)
Glycosyltransferases/chemistry , Milk, Human/chemistry , Oligosaccharides/chemical synthesis , Female , Humans , Microarray Analysis , Oligosaccharides/chemistry
6.
J Biol Chem ; 292(27): 11243-11249, 2017 07 07.
Article in English | MEDLINE | ID: mdl-28416607

ABSTRACT

Streptococcus agalactiae (group B Streptococcus, GBS) is a leading cause of invasive bacterial infections in newborns, typically acquired vertically during childbirth secondary to maternal vaginal colonization. Human milk oligosaccharides (HMOs) have important nutritional and biological activities that guide the development of the immune system of the infant and shape the composition of normal gut microbiota. In this manner, HMOs help protect against pathogen colonization and reduce the risk of infection. In the course of our studies of HMO-microbial interactions, we unexpectedly uncovered a novel HMO property to directly inhibit the growth of GBS independent of host immunity. By separating different HMO fractions through multidimensional chromatography, we found the bacteriostatic activity to be confined to specific non-sialylated HMOs and synergistic with a number of conventional antibiotic agents. Phenotypic screening of a GBS transposon insertion library identified a mutation within a GBS-specific gene encoding a putative glycosyltransferase that confers resistance to HMOs, suggesting that HMOs may function as an alternative substrate to modify a GBS component in a manner that impairs growth kinetics. Our study uncovers a unique antibacterial role for HMOs against a leading neonatal pathogen and expands the potential therapeutic utility of these versatile molecules.


Subject(s)
Anti-Bacterial Agents/pharmacology , Milk, Human/chemistry , Oligosaccharides/pharmacology , Streptococcus agalactiae/growth & development , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/isolation & purification , Female , Humans , Oligosaccharides/chemistry , Oligosaccharides/isolation & purification , Streptococcus agalactiae/genetics
7.
Nutr Rev ; 74(10): 635-44, 2016 10.
Article in English | MEDLINE | ID: mdl-27634978

ABSTRACT

Human milk oligosaccharides (HMOs) are complex sugars highly abundant in human milk but currently not present in infant formula. Rapidly accumulating evidence from in vitro and in vivo studies, combined with epidemiological associations and correlations, suggests that HMOs benefit infants through multiple mechanisms and in a variety of clinical contexts. Until recently, however, research on HMOs has been limited by an insufficient availability of HMOs. Most HMOs are found uniquely in human milk, and thus far it has been prohibitively tedious and expensive to isolate and synthesize them. This article reviews new strategies to overcome this lack of availability by generating HMOs through chemoenzymatic synthesis, microbial metabolic engineering, and isolation from human donor milk or dairy streams. Each approach has its advantages and comes with its own challenges, but combining the different methods and acknowledging their limitations creates new opportunities for research and application with the goal of improving maternal and infant health.


Subject(s)
Milk, Human/chemistry , Oligosaccharides/analysis , Oligosaccharides/physiology , Animals , Bacteria/genetics , Bacteria/metabolism , Biomedical Research , Genetic Engineering , Humans , Infant , Infant Formula , Infant Nutritional Physiological Phenomena , Infant, Newborn , Nutritive Value , Oligosaccharides/biosynthesis
8.
Chem Commun (Camb) ; 50(54): 7132-5, 2014 Jul 11.
Article in English | MEDLINE | ID: mdl-24854112

ABSTRACT

A new anomeric linker has been developed that facilitates the purification of glycans prepared by chemoenzymatic approaches and can readily give compounds that are appropriately modified for microarray development or glycan derivatives with a free reducing end that are needed as standards for the development of analytical protocols.


Subject(s)
Polysaccharides/chemistry , Chromatography, High Pressure Liquid , Fluorenes/chemistry , Galectin 3/chemistry
9.
Chem Commun (Camb) ; (2): 172-3, 2004 Jan 21.
Article in English | MEDLINE | ID: mdl-14737534

ABSTRACT

A novel supramolecular host for the uranyl carbonate complex has been designed and synthesized. The modified cyclodextrin host binds uranyl carbonate in water with a stability of 253 M(-1).


Subject(s)
Carbonates/chemistry , Cyclodextrins/chemistry , Uranium/chemistry , Carbonates/analysis , Ethylenediamines/chemistry , Fresh Water/chemistry , Ligands , Magnetic Resonance Spectroscopy , Protein Binding , Protons , Seawater/chemistry , Thermodynamics
SELECTION OF CITATIONS
SEARCH DETAIL
...